TW200736603A - Methods for preparing crystalline rapamycin and measuring crystallinity of rapamycin compounds using differential scanning calorimetry - Google Patents
Methods for preparing crystalline rapamycin and measuring crystallinity of rapamycin compounds using differential scanning calorimetryInfo
- Publication number
- TW200736603A TW200736603A TW095145393A TW95145393A TW200736603A TW 200736603 A TW200736603 A TW 200736603A TW 095145393 A TW095145393 A TW 095145393A TW 95145393 A TW95145393 A TW 95145393A TW 200736603 A TW200736603 A TW 200736603A
- Authority
- TW
- Taiwan
- Prior art keywords
- rapamycin
- methods
- differential scanning
- scanning calorimetry
- preparing crystalline
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Combustion & Propulsion (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analyzing Materials Using Thermal Means (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74800505P | 2005-12-07 | 2005-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200736603A true TW200736603A (en) | 2007-10-01 |
Family
ID=38117222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095145393A TW200736603A (en) | 2005-12-07 | 2006-12-06 | Methods for preparing crystalline rapamycin and measuring crystallinity of rapamycin compounds using differential scanning calorimetry |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070128731A1 (zh) |
EP (1) | EP1957964A2 (zh) |
JP (1) | JP2009518648A (zh) |
KR (1) | KR20080077147A (zh) |
CN (1) | CN101351702A (zh) |
AR (1) | AR058283A1 (zh) |
AU (1) | AU2006322030A1 (zh) |
BR (1) | BRPI0619592A2 (zh) |
CA (1) | CA2630786A1 (zh) |
CR (1) | CR9985A (zh) |
EC (1) | ECSP088519A (zh) |
IL (1) | IL191545A0 (zh) |
NO (1) | NO20082382L (zh) |
PE (1) | PE20071000A1 (zh) |
RU (1) | RU2008120712A (zh) |
TW (1) | TW200736603A (zh) |
WO (1) | WO2007067566A2 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102282457A (zh) * | 2009-01-21 | 2011-12-14 | 拜康有限公司 | 确定西罗莫司稳定性的方法和制备其稳定形式的工艺 |
FR2943539B1 (fr) | 2009-03-31 | 2011-07-22 | Ethypharm Sa | Composition pharmaceutique comprenant un macrolide immunosuppresseur de la famille des limus. |
CN103748456B (zh) * | 2011-08-05 | 2017-02-15 | 科卢斯博知识产权有限公司 | 确定非晶质合金中的结晶性的非破坏性方法 |
US20150139270A1 (en) * | 2012-04-23 | 2015-05-21 | Apple Inc. | Non-destructive determination of volumetric crystallinity of bulk amorphous alloy |
ES2897473T3 (es) | 2013-03-15 | 2022-03-01 | Biosensors Int Group Ltd | Purificación de derivados de la rapamicina |
US9439892B2 (en) | 2013-05-16 | 2016-09-13 | Surmodics, Inc. | Macrolide particulates, methods for preparation, and medical devices associated therewith |
EP3007679B1 (en) * | 2013-06-12 | 2020-11-11 | SurModics, Inc. | Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates |
DE102013110294B4 (de) * | 2013-09-18 | 2016-07-07 | Innora Gmbh | Limus-Depot-Formulierung auf Ballonkathetern |
WO2015181826A1 (en) | 2014-05-27 | 2015-12-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Crystalline coating and release of bioactive agents |
CN105116013A (zh) * | 2015-04-23 | 2015-12-02 | 山东农业大学 | 一种确定金属离子对蛋白酶水解大豆分离蛋白影响的方法 |
JP6531488B2 (ja) * | 2015-05-22 | 2019-06-19 | 日産自動車株式会社 | リチウムイオン二次電池の熱履歴検知方法 |
US10098846B2 (en) | 2016-03-31 | 2018-10-16 | Surmodics, Inc. | Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment |
US11123459B2 (en) | 2016-12-16 | 2021-09-21 | Surmodics, Inc. | Hydrophobic active agent particle coatings and methods for treatment |
US11629222B2 (en) * | 2019-07-01 | 2023-04-18 | Ethicon, Inc. | Calorimetric crystallization method for evaluation of monomer purity |
WO2023158308A1 (en) | 2022-02-18 | 2023-08-24 | Technische Universiteit Delft | Novel method for analyzing dsc data |
NL2031004B1 (en) * | 2022-02-18 | 2023-09-05 | Univ Delft Tech | Novel method for analyzing DSC data |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) * | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US5358909A (en) * | 1991-02-27 | 1994-10-25 | Nippon Steel Corporation | Method of manufacturing field-emitter |
US5358908A (en) * | 1992-02-14 | 1994-10-25 | Micron Technology, Inc. | Method of creating sharp points and other features on the surface of a semiconductor substrate |
GB9313650D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
US5385908A (en) * | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Hindered esters of rapamycin |
US5385909A (en) * | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Heterocyclic esters of rapamycin |
US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
EP0884585A3 (de) * | 1997-06-06 | 1999-12-29 | Netzsch Gerätebau GmbH | Vorrichtung zur Differential-Scanning-Kalorimetrie |
GB9826882D0 (en) * | 1998-12-07 | 1999-01-27 | Novartis Ag | Organic compounds |
US6277983B1 (en) * | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
ES2177373B1 (es) * | 1999-11-26 | 2003-11-01 | Astur Pharma Sa | Preparacion de azitromicina en su forma no cristalina |
DK1319008T3 (da) * | 2000-09-19 | 2009-02-09 | Wyeth Corp | Vandoplöselige rapamycinestere |
WO2003033097A2 (en) * | 2001-10-17 | 2003-04-24 | E.I. Du Pont De Nemours And Company | Rotor-stator apparatus and process for the formation of particles |
US20060169199A1 (en) * | 2003-03-31 | 2006-08-03 | Vilmos Keri | Crystallization and purification of macrolides |
ATE378345T1 (de) * | 2003-07-24 | 2007-11-15 | Teva Gyogyszergyar Zartkoeruee | Verfahren zur aufreinigung von makroliden |
WO2005016935A2 (en) * | 2003-08-07 | 2005-02-24 | Wyeth | Regioselective synthesis of cci-779 |
BRPI0414066A (pt) * | 2003-09-03 | 2006-10-24 | Wyeth Corp | 42-éster de rapamicina amorfo com ácido 3-hidróxi-2-( hidroximetil )-2-metilproipiÈnico e composições farmacêuticas que o contenha |
WO2005105811A1 (en) * | 2004-04-14 | 2005-11-10 | Wyeth | Regiospecific synthesis of rapamycin 42-ester derivatives |
AU2005238432A1 (en) * | 2004-04-14 | 2005-11-10 | Wyeth | Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
WO2006038972A1 (en) * | 2004-08-10 | 2006-04-13 | Wyeth | Cci-779 derivatives and methods of making same |
RU2394036C2 (ru) * | 2004-12-20 | 2010-07-10 | Вайет | Аналоги рапамицина и их применение при лечении неврологических, пролиферативных и воспалительных заболеваний |
MX2007007409A (es) * | 2004-12-20 | 2007-07-12 | Wyeth Corp | Derivados de rapamicina y los usos de los mismos en el tratamiento de trastornos neurologicos. |
MX2007009590A (es) * | 2005-02-09 | 2007-09-12 | Wyeth Corp | Polimorfo cci-779 y uso del mismo. |
CA2599580A1 (en) * | 2005-03-02 | 2006-09-08 | Wyeth | Recovery of cci-779 from mother liquors |
CN101137659A (zh) * | 2005-03-07 | 2008-03-05 | 惠氏公司 | 42-o-(2-羟基)乙基-雷帕霉素的氧杂环庚烷异构体 |
-
2006
- 2006-12-06 AR ARP060105389A patent/AR058283A1/es unknown
- 2006-12-06 AU AU2006322030A patent/AU2006322030A1/en not_active Abandoned
- 2006-12-06 EP EP06847503A patent/EP1957964A2/en not_active Withdrawn
- 2006-12-06 US US11/634,694 patent/US20070128731A1/en not_active Abandoned
- 2006-12-06 BR BRPI0619592A patent/BRPI0619592A2/pt not_active IP Right Cessation
- 2006-12-06 JP JP2008544451A patent/JP2009518648A/ja active Pending
- 2006-12-06 TW TW095145393A patent/TW200736603A/zh unknown
- 2006-12-06 PE PE2006001569A patent/PE20071000A1/es not_active Application Discontinuation
- 2006-12-06 KR KR1020087013406A patent/KR20080077147A/ko not_active Application Discontinuation
- 2006-12-06 RU RU2008120712/28A patent/RU2008120712A/ru not_active Application Discontinuation
- 2006-12-06 CA CA002630786A patent/CA2630786A1/en not_active Abandoned
- 2006-12-06 CN CNA2006800461020A patent/CN101351702A/zh not_active Withdrawn
- 2006-12-06 WO PCT/US2006/046445 patent/WO2007067566A2/en active Application Filing
-
2008
- 2008-05-19 IL IL191545A patent/IL191545A0/en unknown
- 2008-05-19 CR CR9985A patent/CR9985A/es not_active Application Discontinuation
- 2008-05-26 NO NO20082382A patent/NO20082382L/no not_active Application Discontinuation
- 2008-06-09 EC EC2008008519A patent/ECSP088519A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2009518648A (ja) | 2009-05-07 |
KR20080077147A (ko) | 2008-08-21 |
EP1957964A2 (en) | 2008-08-20 |
PE20071000A1 (es) | 2007-10-10 |
WO2007067566A2 (en) | 2007-06-14 |
IL191545A0 (en) | 2008-12-29 |
US20070128731A1 (en) | 2007-06-07 |
WO2007067566A3 (en) | 2008-01-24 |
NO20082382L (no) | 2008-09-04 |
BRPI0619592A2 (pt) | 2016-09-06 |
AU2006322030A1 (en) | 2007-06-14 |
ECSP088519A (es) | 2008-07-30 |
RU2008120712A (ru) | 2010-01-20 |
CA2630786A1 (en) | 2007-06-14 |
CN101351702A (zh) | 2009-01-21 |
AR058283A1 (es) | 2008-01-30 |
CR9985A (es) | 2008-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200736603A (en) | Methods for preparing crystalline rapamycin and measuring crystallinity of rapamycin compounds using differential scanning calorimetry | |
WO2007136510A3 (en) | Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha | |
JO2548B1 (en) | Beta crystalline form of epabradine hydrochloride, its preparation process and pharmaceutical ingredients containing it | |
MX2008008298A (es) | Sal de sulfato de hidrogeno novedosa. | |
HUP0500170A2 (en) | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them | |
UA90266C2 (ru) | ДЕЛЬТА де-КРИСТАЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ЕЕ СОДЕРЖИТ | |
UA90265C2 (ru) | Дельта-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
GB2431927A9 (en) | 1,2-Disubstituted indoles & derivatives thereof astherapeutic 5-iipoxygenase-activating protein (fl ap) inhibitors | |
TW200720232A (en) | Crystalline solid forms of tigecycline and methods of preparing same | |
RS55499B1 (sr) | Novi kristalni oblik iii agomelatina, postupak njegove proizvodnje i farmaceutske kompozicije koje ga sadrže | |
ZA200801890B (en) | Novel crystalline form of a pyridazino (4, 5-B) indole derivative | |
WO2007010555A3 (en) | Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof | |
SG170054A1 (en) | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | |
FR2860224B1 (fr) | Solide cristallise im-12 et son procede de preparation | |
WO2007047671A3 (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
IL186062A0 (en) | Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
WO2007016029A3 (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
TW200637832A (en) | Process for preparing amorphous valsartan | |
TW200740771A (en) | Process for the synthesis of progesterone receptor modulators | |
TW200708512A (en) | Crystal of aminopyrrolidine derivative and production method thereof | |
ZA200803526B (en) | Process for stabilization of bacterial cells | |
GB0525710D0 (en) | An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds | |
EP1882417A4 (en) | PROCESS FOR THE PREPARATION OF YOGNE WITHOUT MICROBIAL CONTAMINATION | |
WO2008056377A3 (en) | Polymorphic forms of rimonabant | |
ZA200706249B (en) | Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same |